Diabetes News and Research

Latest Diabetes News and Research

Roche scientist honored with 2009 Meienhofer Award for excellence in peptide chemistry

Waleed Danho, Ph.D., Distinguished Research Leader at Roche was honored last week as the 2009 recipient of the Meienhofer Award for excellence in peptide chemistry at the international peptide symposium, RCCPS (http://www.rochecolorado.com/PeptideSymp09/).

8 Oct 2009

New Everyware Medical Gateway solution to remotely monitor treatment for diabetic patients

Eurotech Group, a leading supplier of embedded technologies, products, and systems, announces today the Everyware(TM) Medical Gateway designed to help physicians remotely monitor and adjust the treatment of their diabetes patients.

8 Oct 2009

Centric Health Corporation, PrevCan enter into an agreement to form a strategic alliance

Centric Health Corporation (TSX: CHH), a diversified healthcare company, today announced that it has entered into an agreement to form a strategic alliance with PrevCan, Inc. ("INTERxVENT Canada").

8 Oct 2009

Variation in human genomes is key to understanding inherited differences between health and disease

In research published today by Nature, an international team describes the finest map of changes to the structure of human genomes and a resource they have developed for researchers worldwide to look at the role of these changes in human disease.

8 Oct 2009

Beth Israel Deaconess Medical Center neurologist elected as ANA Honorary Member

Louis R. Caplan, MD, Senior Neurologist at Beth Israel Deaconess Medical Center (BIDMC) and a leader in the treatment and research of strokes, has been elected an Honorary Member of the American Neurological Association (ANA). As the organization's highest honor, Honorary Membership is reserved for select individuals who have made unique contributions to neurology and neurological science throughout their careers.

8 Oct 2009

Clinical and health status outcomes information repository of heart attack patients completed

An important observational registry evaluating processes of care and one-year outcomes of over 4300 heart attack patients is now being completed. Researchers at the Saint Luke's Mid America Heart Institute in Kansas City, MO have led this observational research study in collaboration with 23 other hospitals throughout the U.S.

8 Oct 2009

eHealth Ontario take steps to regain public's trust

eHealth Ontario today pledged that the agency will regain the public's trust by delivering concrete results and ensuring that the issues of procurement and governance reported by the Auditor General will not be repeated.

8 Oct 2009

Antidotes effective for treating acute liver failure patients in early stages of disease

The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other causes if given before severe injury occurs, UT Southwestern Medical Center researchers and their colleagues at 21 other institutions have found.

8 Oct 2009

Obesity and diabetes-2 increase the risk of serious health problems and reduce quality of life

Over the last 10-20 years, the number of cases of obesity and diabetes-2 has risen dramatically. The WHO considers obesity-related illnesses to be one of the world's biggest health problems. Obesity and diabetes-2 do not just reduce the quality of life but also dramatically increase the risk of serious health problems, such as cardiovascular diseases.

8 Oct 2009

Alaska Dentist honored with the Robert Wood Johnson Foundation's Community Health Leader Award

The Robert Wood Johnson Foundation (RWJF) today announced its selection of Amanda Gaynor Ashley, D.M.D., Ms.Edu., director of the Samuel Simmonds Memorial Hospital Dental Clinic in Barrow, Alaska, to receive a Community Health Leaders Award. She is one of 10 extraordinary Americans who will receive the RWJF honor for 2009 at a ceremony this evening at the Mayflower Hotel in Washington, D.C.

8 Oct 2009

CHEO researchers identify protein that inhibits insulin production

One of the biggest mysteries about diabetes is why specialized cells in the pancreas stop secreting insulin, which the body needs in order to store glucose from food. A team from the Children's Hospital of Eastern Ontario (CHEO) Research Institute has identified a protein that inhibits insulin production in mice - work that offers a new way of understanding, and perhaps of one day treating, both Type 1 and Type 2 diabetes.

8 Oct 2009

Napo Pharmaceuticals hosts educational panel to address global health and environment

Napo Pharmaceuticals, Inc. (Napo) recently hosted an educational panel to address the impact of the lack of access to clean water and enteric disease on global health, the environment, and human rights.

8 Oct 2009

U.N. appeals for $74m to provide emergency assistance in the Philippines; health-effects of other natural disasters

The U.N. on Tuesday launched an appeal for $74 million "to provide emergency assistance to hundreds of thousands of victims of two catastrophic typhoons that have struck the Philippines in less than two weeks," VOA News reports (Schlein, 10/6).

8 Oct 2009

New study to assess the risk of heart disease in diabetics

In a new international partnership, Dr. Randy Nelson, a researcher at Arizona State University's Biodesign Institute, and Dr. Tai E-Shyong , associate professor at Singapore's National University Hospital, National University Health System (NUHS), have teamed up to assess the risk of heart disease in diabetics with greater accuracy.

8 Oct 2009

Joslin Diabetes Center and Diabetica Research Solutions join to raise diabetes awareness

Joslin Diabetes Center (Joslin), the world-renowned leader in diabetes research and clinical care, and Diabetica Research Solutions, Inc. (DRSI), makers of drsi™ ReStore! Energy, the only energy and hydration formula specifically designed for the needs of people with diabetes, today announced they will work together to support diabetes causes and programs to which they are deeply committed, and help to educate others and raise awareness about diabetes, its causes and solutions, throughout the world.

8 Oct 2009

Antioxidants can contribute to early onset of Type 2 diabetes

An international team of scientists, led by Monash University researchers, has found that anti-oxidants commonly touted for their health-promoting benefits, could contribute to the early onset of Type 2 diabetes.

8 Oct 2009

Entest BioMedical applies for Phase II grant from National Cancer Institute

Entest BioMedical, Inc. a majority owned subsidiary of Bio-Matrix Scientific Group, Inc. announced today that it has applied for an Exploratory/Development Phase II grant from the National Cancer Institute (NCI).

8 Oct 2009

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

Amarillo Biosciences, Inc. today announced that it has agreed to a strategic partnership with Intas Pharmaceuticals Limited (Intas), one of the top 20 pharmaceutical companies in India, whereby Intas will sponsor clinical trials of ABI's orally administered interferon-alpha lozenges in order to combat influenza. Intas will pay ABI a royalty on net sales after marketing approval is obtained in India.

8 Oct 2009

MENA's diabetes action plan to improve the prevention, treatment and care of diabetes

International Diabetes Federation Middle East and North Africa Region (MENA) today launched a diabetes action plan, marking a major step forward towards optimal disease management in type 2 diabetes. The MENA action plan aims to improve the prevention, treatment and care of diabetes, which has reached epidemic proportions in the region and has overtaken wider communicable diseases as a health risk.

8 Oct 2009

FDA approves Daiichi Sankyo's sNDA for Welchol

Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy.

7 Oct 2009

Diabetes News and Research

Latest Diabetes News and Research

Roche scientist honored with 2009 Meienhofer Award for excellence in peptide chemistry

New Everyware Medical Gateway solution to remotely monitor treatment for diabetic patients

Centric Health Corporation, PrevCan enter into an agreement to form a strategic alliance

Variation in human genomes is key to understanding inherited differences between health and disease

Beth Israel Deaconess Medical Center neurologist elected as ANA Honorary Member

Clinical and health status outcomes information repository of heart attack patients completed

eHealth Ontario take steps to regain public's trust

Antidotes effective for treating acute liver failure patients in early stages of disease

Obesity and diabetes-2 increase the risk of serious health problems and reduce quality of life

Alaska Dentist honored with the Robert Wood Johnson Foundation's Community Health Leader Award

CHEO researchers identify protein that inhibits insulin production

Napo Pharmaceuticals hosts educational panel to address global health and environment

U.N. appeals for $74m to provide emergency assistance in the Philippines; health-effects of other natural disasters

New study to assess the risk of heart disease in diabetics

Joslin Diabetes Center and Diabetica Research Solutions join to raise diabetes awareness

Antioxidants can contribute to early onset of Type 2 diabetes

Entest BioMedical applies for Phase II grant from National Cancer Institute

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

MENA's diabetes action plan to improve the prevention, treatment and care of diabetes

FDA approves Daiichi Sankyo's sNDA for Welchol

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diabetes News and Research

Latest Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in